Svendsen J H, Madsen J K, Saunamäki K I, Grande P, Pedersen F, Clemmensen P, Ha Edersdal C, Granborg J
Department of Cardiology, Gentofte Hospital, Denmark.
Eur Heart J. 1992 Jan;13(1):33-8. doi: 10.1093/oxfordjournals.eurheartj.a060044.
Several studies have shown that infarct size is reduced following thrombolytic treatment in patients with acute myocardial infarction. Exercise test variables, such as an impaired heart rate response during exercise, are known to be related to left ventricular function and patient prognosis following acute myocardial infarction. The present study was performed to compare exercise test variables in acute myocardial infarction patients following either intravenous thrombolysis or placebo. Symptom-limited bicycle ergometer tests, carried out 1-2 weeks from the infarction, were performed in 85 patients randomized to intravenous streptokinase (N = 41) or placebo (N = 44) given within 12 h from onset of symptoms. At rest heart rate, systolic blood pressure and rate-pressure product were similar in the two groups. At maximum workload the streptokinase treated patients had a higher median maximal heart rate than controls (136 vs. 126 b.min-1, P less than 0.01) but only a trend towards higher systolic blood pressure was seen (175 vs. 163 mmHg, P = 0.09). Rate-pressure product at maximal exercise was 23,620 vs. 20,100 mmHg.b.min-1 respectively, (P less than 0.01). Total exercise time, ST-segment deviation, occurrence of angina pectoris and left ventricular ejection fraction were similar in the two groups. The trend towards an increased heart rate at maximum workload in streptokinase-treated patients was seen at all levels of left ventricular ejection fraction, and at all levels of exercise capacity.(ABSTRACT TRUNCATED AT 250 WORDS)
多项研究表明,急性心肌梗死患者接受溶栓治疗后梗死面积会减小。运动测试变量,如运动期间心率反应受损,已知与急性心肌梗死后的左心室功能和患者预后相关。本研究旨在比较急性心肌梗死患者接受静脉溶栓或安慰剂治疗后的运动测试变量。对85例患者进行了症状受限的自行车测力计测试,这些患者在症状发作后12小时内被随机分为静脉注射链激酶组(N = 41)或安慰剂组(N = 44),测试在梗死发生后1 - 2周进行。两组患者静息时的心率、收缩压和心率血压乘积相似。在最大工作量时,链激酶治疗组患者的最大心率中位数高于对照组(136对126次·分钟⁻¹,P < 0.01),但仅观察到收缩压有升高趋势(175对163 mmHg,P = 0.09)。最大运动时的心率血压乘积分别为23,620和20,100 mmHg·分钟⁻¹,(P < 0.01)。两组患者的总运动时间、ST段偏移、心绞痛发生率和左心室射血分数相似。在所有左心室射血分数水平和所有运动能力水平上,均观察到链激酶治疗组患者在最大工作量时心率升高的趋势。(摘要截短至250字)